Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice

By Jun Li, Cecilia Ying Ju Sung, N. Lee, Yueqiong Ni, Jussi Pihlajamäki, Gianni Panagiotou, H. El‐Nezami. Proceedings of the National Academy of Sciences of the United States of America, 2016

597 citations recorded by the source corpus.

Subfields: Molecular Biology, Oncology, Physiology

View Paper: https://www.semanticscholar.org/paper/798e76cc019b7f6efdc8d3228fa7667e2463466f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. A. Veloo
2. A. Rodriguez-Palacios
3. Leroy Hood
4. B. Parker
5. P. Wearsch

In Physiology

1. A. Veloo
2. A. Rodriguez-Palacios
3. B. Parker
4. P. Wearsch

Citations in the corpus

• Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma (2018, background): “36 This study is the first report to illustrate gut microbial characteristics in patients with early HCC.”
• The Genus Alistipes: Gut Bacteria With Emerging Implications to Inflammation, Cancer, and Mental Health (2020, background): “Of interest, Alistipes has been observed increasing among patients taking probiotics in an anti-inflammatory effect background (45).”
• Human Gut Microbiota and Gastrointestinal Cancer (2018, background): “Prohep administration helps downregulate the Th17 frequency and the production of IL-1, inhibits the angiogenesis, and promotes the differentiation of anti-inflammatory Treg cells in the GI tract [217].”